Clinical Trial Update: Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM) [NA]

View source ↗

Summary

A clinical trial update for HIRACUM evaluating hypofractionated IMRT with concurrent chemotherapy in muscle-invasive bladder cancer, currently recruiting at Sam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Bladder Cancer | NA | Status: RECRUITING